Minocin is a medication with the active ingredient minocycline. It is also known by other names like Dynacin and Minocycline. Minocin is mainly used to treat bacterial infections, including acne, respiratory tract infections, and urinary tract infections.
Typically, Minocin is priced from £1.49 up to £2.41 per pills. Variance in price is rooted in the pack’s volume and the concentration of active entities (15 or 180 mg).
Minocin (minocycline hydrochloride) is used to treat various bacterial infections. It is effective against a broad range of gram-positive and gram-negative bacteria. Specific conditions include respiratory infections, skin infections, severe acne, and urinary tract infections. Minocin is also used to treat other infections that are resistant to other antibiotics.
The usual adult dose of Minocin is 200 mg initially, followed by 100 mg every 12 hours. Pediatric dosage depends on the child’s weight; generally, 4 mg per kg initially, then 2 mg per kg every 12 hours. Dosages should be individualized based on severity of infection and patient response. Minocin can be taken with or without food, but it is recommended to take it with a full glass of water.
Minocin is a bacteriostatic antibiotic, part of the tetracycline class. It works by inhibiting bacterial protein synthesis. Minocycline binds to the 30S ribosomal subunit in the bacterial cell, preventing the addition of new amino acids to the growing peptide chain. This inhibits the ability of bacteria to grow and reproduce.
Minocin is well absorbed from the gastrointestinal tract, with peak plasma concentrations reached within 1-2 hours. The drug binds extensively to plasma proteins, about 70-75%. It has a half-life of approximately 11-22 hours, allowing for twice-daily dosing. Minocycline is widely distributed throughout body tissues and fluids, including the central nervous system.
Minocin is contraindicated in individuals with hypersensitivity to minocycline or other tetracyclines. It is also not recommended for use during pregnancy or breastfeeding due to potential adverse effects on fetal and infant development. Severe liver dysfunction also contraindicates the use of Minocin.
Concurrent use of Minocin with anticoagulants may prolong prothrombin time. Antacids containing aluminum, magnesium, or calcium can decrease the absorption of minocycline. Minocin may interact with penicillin, reducing its bactericidal effects. Combining Minocin with retinoids can increase intracranial pressure.
Common side effects include gastrointestinal disturbances such as nausea and vomiting. Central nervous system effects like dizziness, lightheadedness, and vertigo are also reported. Dermatological reactions can include rash and photosensitivity. More severe reactions include hepatotoxicity and hypersensitivity reactions like anaphylaxis.
Minocin is classified as pregnancy category D. It can cause permanent discoloration of teeth and affect bone growth in the fetus. Minocin is excreted in human milk and can cause adverse effects in nursing infants. It is advised that mothers either discontinue nursing or discontinue the drug.
Patients on long-term Minocin therapy should have periodic laboratory evaluations, including renal and hepatic function tests. Blood counts should be monitored regularly to detect potential bone marrow suppression. Regular skin and dental examinations are necessary to monitor for signs of photo toxicity and discoloration.
Minocin should be stored at room temperature, away from light and moisture. It should be kept out of reach of children and not used beyond the expiration date. The medication container should be tightly closed to maintain drug efficacy and stability.